ID: ALA103042

Max Phase: Preclinical

Molecular Formula: C27H24N4O6

Molecular Weight: 500.51

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCC1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3cc(OCCNC(=O)c4ccc[nH]4)ccc3nc2-1

Standard InChI:  InChI=1S/C27H24N4O6/c1-2-27(35)19-12-22-23-16(13-31(22)25(33)18(19)14-37-26(27)34)10-15-11-17(5-6-20(15)30-23)36-9-8-29-24(32)21-4-3-7-28-21/h3-7,10-12,28,35H,2,8-9,13-14H2,1H3,(H,29,32)

Standard InChI Key:  MUNSVZAILUSNRB-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 500.51

Molecular Weight (Monoisotopic): 500.1696

AlogP: 2.22

#Rotatable Bonds: 6

Polar Surface Area: 135.54

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 11.71

CX Basic pKa: 3.15

CX LogP: 0.94

CX LogD: 0.94

Aromatic Rings: 4

Heavy Atoms: 37

QED Weighted: 0.24

Np Likeness Score: 0.27

References

1. Zhao R, Oreski B, Lown J.  (1995)  Synthesis and antitumor activity of camptothecin derivatives bearing five-membered heterocycle containing 10-substituents,  5  (24): [10.1016/0960-894X(95)00538-5]

Source

Source(1):

• Scientific Literature